###begin article-title 0
###xml 58 62 <span type="species:ncbi:10090">Mice</span>
IL-2 Regulates SEB Induced Toxic Shock Syndrome in BALB/c Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: AAK BS. Performed the experiments: AAK SP. Analyzed the data: AAK BS. Contributed reagents/materials/analysis tools: BS. Wrote the paper: AAK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 313 314 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 143 164 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Toxic Shock Syndrome (TSS) is characterized by fever, rash, hypotension, constitutional symptoms, and multi-organ involvement and is caused by Staphylococcus aureus enterotoxins such as Staphylococcal Enterotoxin B (SEB). SEB binds to the MHC-IIalpha chain and is recognized by the TCRbeta chain of the Vbeta8 TCR+ T cells. The binding of SEB to Vbeta chain results in rapid activation of T cells and production of inflammatory cytokines, such as Interleukin-2 (IL-2), Interferon-gamma and Tumor Necrosis Factor-alpha which mediate TSS. Although IL2 was originally identified as the T cell growth factor and was proposed to contribute to T cell differentiation, its role in TSS remains unexplored.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 288 291 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
###xml 145 149 <span type="species:ncbi:10090">Mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
Mice were injected with D-Gal (25 mg/mouse). One hour after D-Galactosamine (D-Gal) injection each mouse was injected with SEB (20 microg/mouse. Mice were then observed for 72 hrs and death was recorded at different times. We tested Interleukin-12, IFNgamma, and IL-2 deficient mice (IL-2-/-), but only the IL-2 deficient mice were resistant to SEB induced toxic shock syndrome. More importantly reconstitution of IL-2 in IL-2 deficient mice restored the shock. Interestingly, SEB induced IL-2 production from T cells was dependent on p38MAPK activation in macrophages as inhibition of it in macrophages significantly inhibited IL-2 production from T cells.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
This study shows the importance of IL -2 in TSS which has not been previously explored and it also shows that regulating macrophages function can regulate T cells and TSS.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S aureus</italic>
###xml 241 244 241 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Schrock1">[1]</xref>
###xml 347 350 347 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Acharya1">[2]</xref>
###xml 555 558 552 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Papageorgiou1">[3]</xref>
###xml 665 673 662 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S aureus</italic>
###xml 721 724 718 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Saha1">[4]</xref>
###xml 852 855 849 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Lee1">[5]</xref>
###xml 1020 1023 1017 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Herman1">[6]</xref>
###xml 1180 1183 1177 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Davison1">[7]</xref>
###xml 1327 1330 1324 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Kotzin1">[8]</xref>
###xml 1332 1335 1329 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Miethke1">[9]</xref>
###xml 1449 1453 1446 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Neumann1">[10]</xref>
###xml 1527 1531 1516 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Miethke2">[11]</xref>
###xml 1670 1674 1659 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Smith1">[12]</xref>
###xml 1748 1751 1737 1740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1930 1934 1919 1923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Aicher1">[13]</xref>
###xml 1774 1778 <span type="species:ncbi:10090">mice</span>
TSS is a superantigen-mediated disease. Superantigens are a group of proteins (S aureus toxins in the case of TSS) that are able to activate the immune system by bypassing certain steps in the usual antigen-mediated immune response sequence [1]. Superantigens are not processed within the antigen-presenting cell before being presented to T cells [2], instead, they bind directly to the alpha chain of the major histocompatibility complex, class II (MHC-II), and are recognized by the Vbeta chain of T cell receptor to trigger a massive T-cell activation [3]. Staphylococcal Enterotoxin B (SEB), a superantigen, is among the toxins produced by toxigenic strains of S aureus, and it can cause TSS in a variety of settings [4]. SEB is the toxin that most commonly causes classic food poisoning. It has also been demonstrated to cause a non-menstrual TSS [5]. In addition, staphylococcal infection in surgical operations can also cause TSS. It is viewed that the mechanism of SEB-induced TSS is a massive T cell activation [6]. While conventional antigens activate only about 0.01% to 0.1% of the T-cell population, super antigens can activate 5%-30% of the entire T cell population [7]. Superantigens lead to a rapid burst of cytokines, especially tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1), and IL-6 and IL-2 [8], [9]. These cytokines are responsible for a capillary leak syndrome and account for many of the clinical signs of TSS [10]. Although TNFalpha and IFNgamma are shown to be the major players in TSS [11], the role of IL-2 is not well studied, despite its original identification as a T cell growth factor and its role in T cell proliferation [12]. Therefore we compared SEB induced TSS in BALB/c and IL-2 deficient (IL-2-/-) in BALB/c background mice. Since activation status of antigen presenting cells (APCs) may also play a role in TSS and the crucial role of p38MAPK has already been shown in APCs [13], we studied the role of p38MAPK in SEB induced TSS. Our data demonstrates that IL-2 is essential for SEB induced TSS and that p38MAPK plays an important role in the process.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
SEB Leads to the Activation of p38MAPK in Peritoneal Macrophages
###end title 11
###begin p 12
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Andreae1">[14]</xref>
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Khan1">[15]</xref>
###xml 420 429 412 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g001">Figure 1A</xref>
###xml 612 621 600 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g001">Figure 1B</xref>
###xml 712 716 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-tenHove1">[16]</xref>
###xml 888 897 872 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g001">Figure 1C</xref>
It was reported recently that ligation of MHC-II by LAG3 or anti-MHC-II leads to activation of p38MAPK [14], [15]. p38MAPK has been shown to induce TNFalpha in the case of LPS stimulation of macrophages systems. Since TSS is caused by TNFalpha, therefore we examined the activation of p38MAPK by SEB. Macrophages were treated with SEB for different times and we observed a time dependent increase in p38MAPK activation (Figure 1A) peaking at 30 mins. Similarly, cells were stimulated for 30 mins with indicated doses of SEB and we observed a dose dependent increase in p38MAPK activation peaking at 2 microg/ml (Figure 1B). To determine the effect of SB-203580 (a p38MAPK inhibitor) on the activation of p38MAPK [16], macrophages were incubated with SB-203580 for 2 hrs and then stimulated with SEB (2 microg/ml) for 30 mins; dose dependent inhibition of p38MAPK activation was observed (Figure 1C). This suggests that p38MAPK is activated by SEB in macrophages.
###end p 12
###begin title 13
SEB induces p38MAPK phosphorylation in peritoneal Macrophages.
###end title 13
###begin p 14
(A). PMPhis were stimulated for indicated times and cell lysates were analyzed by western blotting using an anti-phospho p38MAPK specific antibody. Equal loading was confirmed by reprobing the stripped membrane with a p38MAPK specific antibody. (B) Macrophages were stimulated with indicated doses of SEB and cell lysates were analyzed by western blotting using an anti-phospho p38MAPK specific antibody. Equal loading was confirmed by reprobing the stripped membrane with a p38MAPK specific antibody. (C) Macrophages were preincubated with indicated doses of SB-203580 for 2 hrs and stimulated with 2 microg/ml of SEB for 30 minutes, and then the lysates were analyzed by western blotting against phospho p38MAPK. Equal loading was confirmed by reprobing the stripped membrane with a p38MAPK specific antibody.
###end p 14
###begin title 15
Inhibition of p38MAPK in Macrophages Modulates T Cell Function
###end title 15
###begin p 16
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Baxter1">[17]</xref>
###xml 338 339 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 550 562 534 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g002">Figure 2A, B</xref>
###xml 886 895 862 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g002">Figure 2c</xref>
###xml 981 990 957 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g002">Figure 2d</xref>
###xml 629 633 <span type="species:ncbi:10090">Mice</span>
###xml 718 722 <span type="species:ncbi:10090">Mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 918 922 <span type="species:ncbi:10090">mice</span>
###xml 1058 1062 <span type="species:ncbi:10090">mice</span>
SEB binds to TCR and leads to the proliferation of T cells, and it also signals in APCs [17]. We examined the effect of p38MAPK inhibition in macrophages and its subsequent effect on T cell function. Macrophages were pretreated with SB-203580 (2 microg/ml, 4 microg/ml and 8 microg/ml) for 2 hrs, washed and then were co-cultured with CD4+ T cells. SEB (2 microg/ml) was added to the co culture for 72 hrs, and T cell proliferation and IL-2 production were assessed. We observed dose-dependent inhibition of T cell proliferation and IL-2 production (Figure 2A, B). We next tested the effect of SB-203580 on the induction of TSS. Mice were injected with SB-203580 and subsequently challenged with a lethal dose of SEB. Mice pretreated with SB-203580 had lower circulating levels of TNF-alpha but this was not significant as compared to circulating levels of TNF-alpha in untreated mice (Figure 2c). SB203580 pretreated mice had prolonged survival as compared to untreated controls (Figure 2d). The observation was consistent with the incomplete protection of mice from TSS.
###end p 16
###begin title 17
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Macrophage pretreatment with SB-203580 inhibits SEB induced IL-2 production in T cells and imparts resistance to SEB induced TSS in BALB/mice.
###end title 17
###begin p 18
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 480 485 <span type="species:ncbi:10090">mouse</span>
###xml 658 662 <span type="species:ncbi:10090">Mice</span>
###xml 732 736 <span type="species:ncbi:10090">Mice</span>
(A) Peritoneal MPhis were preincubated with indicated doses of SB-203580 for 2 hrs and cells were washed and then T cells were added to these macrophage cultures these cultures were then stimulated with SEB (2 microg/ml) for 72 hours and proliferation was measured by adding thymidine at 60 hours for 12 hours. (B) ELISA for IL-2 was done from the supernatant collected at sixty hours from above set. (C) BALB/c mice were injected intraperitoneally (IP) with SB-203580 (25 microg/mouse) and vehicle control (DMSO) (data not shown) one hour before D-Gal injection, then the SEB (20 microg/ml) was injected after one hour after D-Gal injection in the footpad. Mice were bled and ELISA was done to assess serum levels of TNFalpha (D). Mice were then observed for mortality.
###end p 18
###begin title 19
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 71 74 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
###xml 75 79 <span type="species:ncbi:10090">Mice</span>
IL-2-/- Mice Are Resistant to SEB Induced TSS but IL-12-/- and IFNgamma-/- Mice Are Susceptible to TSS
###end title 19
###begin p 20
###xml 123 126 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 398 401 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 460 463 448 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 553 556 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 581 584 565 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 627 634 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g003">Fig. 3b</xref>
###xml 811 812 795 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 855 858 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 976 979 960 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1031 1038 1015 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g003">Fig. 3c</xref>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 166 170 <span type="species:ncbi:10090">Mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">Mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
IFNgamma has been implicated as one of the factors in Lipopolysaccharide (LPS) induced shock so we checked whether IFNgamma-/- mice are resistant to SEB induced TSS. Mice were challenged with a lethal dose of SEB and mortality was observed. We observed that IFNgamma mice were susceptible to SEB induced TSS. Since TSS is the result of high inflammatory cytokine production we checked whether IL-12-/- mice are resistant to SEB induced TSS. WT BALB/c and IL-12-/- mice were challenged with a lethal dose of SEB and observed for death. Much like INFgamma-/- mice we found that IL-12-/- mice were susceptible to SEB induced TSS (Fig. 3b), suggesting that IL-12 is not involved in SEB induced TSS. Since SEB induced IL-2 production was inhibited when SB203580-pretreated macrophages were co-cultured with naive CD4+ T cells, we checked TSS induction in IL-2 -/- mice. Mice were challenged with a lethal dose of SEB and death was recorded at different times. We observed that IL-2-/- mice were absolutely resistant to SEB induced TSS (Fig. 3c) suggesting that IL-2 may be involved in SEB induced TSS.
###end p 20
###begin title 21
###xml 14 18 <span type="species:ncbi:10090">mice</span>
IL-2 knockout mice are resistant to SEB induced TSS.
###end title 21
###begin p 22
###xml 23 26 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 206 209 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 378 381 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 452 457 <span type="species:ncbi:10090">mouse</span>
(A) BALB/c and IFNgamma-/- mice were injected IP with D-Gal (25 mg/mouse) and after one hour mice were injected with SEB (20 microg/mouse) in the footpad and death was recorded at indicated times. (B) IL-12-/- and BALB/c mice were injected with D-Gal (25 mg/mouse), after one hour mice were injected with SEB (20 microg/ml) and mortality was recorded at indicated times (C) IL-2-/- mice and BALB/c mice were injected in the footpad with SEB (20 microg/mouse) one hour after D-Gal sensitization and mortality was recorded at indicated times.
###end p 22
###begin title 23
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
IL-2-/- Mice Are Resistant Due to Lower TNFalpha
###end title 23
###begin p 24
###xml 10 13 10 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 84 87 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 288 291 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 332 341 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g004">Figure 4A</xref>
###xml 408 411 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 572 575 556 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 638 641 622 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 694 698 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Bachmann1">[19]</xref>
###xml 700 709 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g004">Figure 4B</xref>
###xml 721 722 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 772 776 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Matsuda1">[20]</xref>
###xml 813 814 797 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 828 831 812 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 916 917 894 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 933 934 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1029 1030 1007 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1045 1046 1023 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1056 1065 1034 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g004">Figure 4C</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
###xml 832 836 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
Since IL-2-/- mice are resistant to TSS, we compared production of TNF-alpha in IL-2-/- and BALB/c wild type mice. SEB-challenged mice were bled after one hour of challenge and ELISA was done to assess circulating levels of TNFalpha. We found that TNF-alpha was significantly less in IL-2-/- mice than that observed in BALB/c mice (Figure 4A). We saw a higher basal level of TNF-alpha in BALB/c and less IL-2-/- mice; this difference could be due to a basal level activity of IL-2 in BALB/c mice. Subsequently, proliferation of splenocytes was tested in wild type and IL-2-/- mice injected with SEB. Proliferation of splenocytes from IL-2-/- mice was found to be higher as previously described [19] (Figure 4B). Since CD4+ T cells are responsible for the induction of TSS [20], we wanted to know the status of CD4+ cells in IL-2-/- mice. We performed FACS for CD4 vs. Vbeta8 and CD8 vs. Vbeta8 to check status of CD4+ T cells and CD8+ T cells from mice injected with SEB for 2 hrs. We found no difference in the population of CD4+T cells and CD8+ T cells (Figure 4C).
###end p 24
###begin title 25
###xml 29 32 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Low level of TNFalpha in IL-2-/- accounts for the resistance against SEB induced TSS.
###end title 25
###begin p 26
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 158 161 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 444 447 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 212 217 <span type="species:ncbi:10090">mouse</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
(A) IL-2-/- and BALB/c mice were bled after one hour after SEB (20 microg/mouse) injection and circulating levels of TNFalpha were assessed by ELISA. (B) IL-2-/- and BALB/c mice were injected with SEB (20 microg/mouse) in the footpad and spleens were collected after three hours from these mice. Splenocytes were prepared and cultured for 72 hours without further stimulation and proliferation was measured. (C) Spleens were collected from IL-2-/- and BALB/c mice, splenocytes were prepared and FACS was done for CD4 vs. Vbeta8 and CD8 vs. Vbeta8.
###end p 26
###begin title 27
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 56 60 <span type="species:ncbi:10090">Mice</span>
Reconstitution with rIL-2 Restores the Shock in IL-2-/- Mice
###end title 27
###begin p 28
###xml 10 13 10 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 319 322 311 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 383 386 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 400 409 388 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g005">Figure 5a</xref>
###xml 627 636 611 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g005">Figure 5b</xref>
###xml 702 705 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 993 1000 965 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008473-g005">Fig. 5c</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 506 511 <span type="species:ncbi:10090">mouse</span>
###xml 514 518 <span type="species:ncbi:10090">Mice</span>
###xml 577 582 <span type="species:ncbi:10090">mouse</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
Since IL-2-/- mice were resistant to TSS, we investigated whether reconstitution of IL-2 can restore the TNF-alpha production. Splenocytes were cultured with or without rIL-2 and were stimulated with SEB. We observed that splenocytes treated with rIL-2 + SEB produced similar levels of TNF-alpha in both BALB/c and IL-2-/- mice suggesting that rIL-2 can restore TNF-alpha in the IL-2-/- splenocytes (Figure 5a). To further confirm the role of IL-2 in SEB induced TSS, mice were injected with rIL-2 (500 ng/mouse). Mice were then challenged with a lethal dose of SEB (20 microg/mouse) and death was recorded at different times (Figure 5b). We found that reconstitution of IL-2 restored the shock in IL-2-/- mice confirming the involvement of IL-2 in SEB induced TSS in BALB/c mice. The same mice were bled one hour after SEB injection and ELISA was done for TNF-alpha. We found an increase in TNF-alpha level with IL-2 reconstitution, confirming that reconstitution of IL-2 restores TNF-alpha (Fig. 5c).
###end p 28
###begin title 29
Reconstitution of IL-2 induces shock.
###end title 29
###begin p 30
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 170 173 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 213 218 <span type="species:ncbi:10090">mouse</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 246 250 <span type="species:ncbi:10090">Mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
(a) Splenocytes were prepared from IL-2-/- and WT mice and stimulated with SEB (2 microg/ml) or SEB + rIL-2 (5 ng/ml) and TNFalpha levels were measured by ELISA. (b) IL-2-/- mice were injected with SEB (20 microg/mouse), and rIL-2 (500 ng/mouse).Mice were then observed for mortality at indicated times. (c) Above mice were bled one hour after SEB injection and ELISA was done to assess circulating levels of TNF-alpha in the serum of these mice.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 166 170 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Lagoo1">[21]</xref>
###xml 685 688 673 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1195 1199 1159 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Burns1">[22]</xref>
###xml 1379 1380 1339 1340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2235 2239 2179 2183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Batten1">[23]</xref>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 924 932 <span type="species:ncbi:9606">patients</span>
###xml 1225 1229 <span type="species:ncbi:10090">mice</span>
###xml 1308 1312 <span type="species:ncbi:10090">mice</span>
###xml 1444 1448 <span type="species:ncbi:10090">mice</span>
###xml 1786 1790 <span type="species:ncbi:10090">mice</span>
###xml 2189 2193 <span type="species:ncbi:10090">mice</span>
###xml 2405 2409 <span type="species:ncbi:10090">mice</span>
SEB binds to MHC-II on APCs and to TCR on T cells producing effects on both cell types. SEB induces IL-12 and TNF-alpha from APCs and IL-2 and TNF-alpha from T cells [21]. TNF-alpha is the common cytokine produced which then induces shock. Our study for the first time explains the importance of signaling molecules like p38MAPK in TSS induction. Since SEB binds to MHC class II and leads to the activation of p38MAPK our results indicate the importance of MHC class II signaling in the regulation of TSS. SEB induces high IL-2 production from T cells. The role of which in the induction of TSS has not been explored. Our results show that IL-2 is involved in induction of TSS, as IL-2-/- mice were found to be absolutely resistant to SEB induced TSS. Interleukin-2 (IL-2) induces high levels of IFN-gamma and TNF-alpha secretion. IL-2 induced secretion of IFN-gamma and TNF-alpha is higher in auto graft recipients than in patients treated by chemotherapy alone. As both TNF-alpha and IFNgamma possess anti-leukemic and anti-infective properties, enhancement of their secretion by IL-2 infusion after autologous bone marrow transplant and induction after chemotherapy is of therapeutic benefit [22]. This study reveals that mice deficient in IL-12 or IFNgamma are susceptible to SEB induced TSS whereas the mice deficient in IL-2 are absolutely resistant to SEB induced TSS. CD4+ T cells are shown to be involved in mediating the TSS, but the mice deficient in IL-2 have comparable amounts of CD4+ T cells and CD8+ T cells, which proliferate more than WT T cells indicating that there could be some other mechanism of TSS induction. Indeed, it is the IL-2 produced TNF-alpha which causes TSS as deficiency of IL-2 reduced TNF-alpha in T cells as well as in the serum of IL-2 deficient mice. Higher proliferation of IL-2 deficient T cells was due to IL-2 induced IL-10 production from T cells, which acts as a regulatory control and regulates T cell proliferation. This phenomenon also helps in maintaining the homeostasis between regulatory T cells and effector T cells. Our study shows that TNF-alpha plays a key role in the induction of TSS, and complete removal of TNF-alpha makes the mice more susceptible to diseases like cancer [23]. Our study shows that deficiency of IL-2 reduces the TNF-alpha production but does not inhibit it completely. This reduction in TNF-alpha production inhibits TSS in mice and hence could be better a strategy to understand the molecular mechanism of TSS.
###end p 32
###begin title 33
Materials and Methods
###end title 33
###begin p 34
All experiments were performed under guidelines and approval of Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) and Institutional Animal Care of National Centre for Cell Science (NCCS), India and used Committee and Institute approved protocols for the animal experimentation.
###end p 34
###begin title 35
###xml 4 8 <span type="species:ncbi:10090">Mice</span>
(1) Mice and Other Reagents
###end title 35
###begin p 36
###xml 428 431 421 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 438 441 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 454 457 443 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
SEB, purchased from Sigma (St Louis, MO) was used in all the experiments. Antibodies anti-IL-2, anti-TNF-alpha, anti-CD4; anti-Vbeta8 and anti-CD25 were from BD-PharMingen. Other antibodies used for western blot like anti-pp38MAPK, anti-p38MAPK were from Santa Cruz Biotechnology (Santa Cruz, CA). Thymidine used was from BRITs (Trombay, INDIA). SB-203580 (a p38MAPK inhibitor) was purchased from Calbiochem (La Jolla, CA). IL-2-/-, IL-12-/- and IFNgamma-/- mice having BALB/c background were purchased from Jackson Laboratories.
###end p 36
###begin title 37
(2) Western Blotting
###end title 37
###begin p 38
###xml 806 810 796 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Khan1">[15]</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:9913">Calf</span>
Western blots were done to determine the p38MAPK phosphorylation. BALB/c mice were injected with 3% thioglycollate intraperitoneally and peritoneal macrophages (PMPhi) were harvested from the peritoneum of the mice and cultured for 12 hrs so that macrophages adhered to the plate. Cells were then washed with RPMI alone (without FCS (Fetal Calf Serum)) to remove the non-adherent cells. Then these cells were stimulated with SEB (2 microg/ml) for different time periods and with different doses of SEB and were also pretreated with a specific inhibitor of p38MAPK in some cases. Cells were lysed with triton X 100 lysis buffer (150 mM NaCl, 25 mM Tris-Cl and 1% triton X 100 pH-7.5) and 20 microg/lane of lysates were loaded onto the gel and blotting was done for p38MAPK phosphorylation and total p38MAPK [15].
###end p 38
###begin title 39
(3) Mortality Assay
###end title 39
###begin p 40
###xml 30 34 30 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-AboudPirak1">[24]</xref>
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 89 92 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">Mice</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 328 333 <span type="species:ncbi:10090">mouse</span>
###xml 356 361 <span type="species:ncbi:10090">mouse</span>
###xml 363 367 <span type="species:ncbi:10090">Mice</span>
###xml 518 523 <span type="species:ncbi:10090">mouse</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
Mice used for mortality assay [24] were BALB/c, IL-2-/- (3-4 weeks, IL-12-/- and IFNgamma-/- mice (4-6 weeks), weighing 15 g-20 g each. Mice were injected with D-Gal (25 mg/mouse) to sensitize them to SEB induced TSS, as these mice are resistant to TSS without D-Gal sensitization. After 1 hr of D-Gal injection, SEB (20 microg/mouse) was injected in each mouse. Mice were then observed for 72 hrs and death was recorded at different times. For reconstitution & neutralization experiments rIL-2 (R&D systems), (500 ng/mouse) was injected intraperitoneally once only, one hour before D-Gal injection. Control mice injected with saline.
###end p 40
###begin title 41
(4) T Cell Purification
###end title 41
###begin p 42
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008473-Trizio1">[25]</xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Spleens from BALB/c and IL-2-/- mice were collected and crushed by using one end frosted slide and centrifuged at 1200 rpm for 8 minutes. Cells were treated with Gey's solution to lyse RBCs and then washed with RPMI+10% FCS. Then this cell suspension was loaded onto nylon wool column to get rid of all cells except T cells. Nylon wool column flow through was subjected to CD4+ T cell negative selection using CD4+ T cell isolation kit from Stem Cell Technologies (VC Canada) [25].
###end p 42
###begin title 43
(5) ELISA
###end title 43
###begin p 44
The ELISA for the indicated cytokines was performed according to the manufacturers protocol (B.D. PharMingen).
###end p 44
###begin title 45
(6) Serum Preparation
###end title 45
###begin p 46
###xml 29 33 <span type="species:ncbi:10090">mice</span>
The control and SEB injected mice were bled and sera were prepared after the refraction of the clots and stored at -70degreesC until used.
###end p 46
###begin title 47
(7) Proliferation
###end title 47
###begin p 48
Splenocytes were stimulated with SEB for 72 hours, thymidine was added at the completion of 60 hours of stimulation and counts were taken in Hewlett Packard Radioactive Scintillation counter.
###end p 48
###begin title 49
(8) FACS
###end title 49
###begin p 50
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were injected with SEB for 2 hrs and then splenocytes were stained for CD4/CD8 vs. Vbeta8.
###end p 50
###begin p 51
###xml 41 45 <span type="species:ncbi:10090">mice</span>
We thank Dr B. Ramanmurthy for providing mice and Dr. Gyan C Mishra for encouraging us to carry out this work and Ms Katie Matatall for correcting the manuscript.
###end p 51
###begin title 52
References
###end title 52
###begin article-title 53
Disease alert.
###end article-title 53
###begin article-title 54
Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
###end article-title 54
###begin article-title 55
Microbial superantigens: from structure to function.
###end article-title 55
###begin article-title 56
Protection against lethal toxic shock by targeted disruption of the CD28 gene.
###end article-title 56
###begin article-title 57
###xml 99 120 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates.
###end article-title 57
###begin article-title 58
Superantigens: mechanism of T-cell stimulation and role in immune responses.
###end article-title 58
###begin article-title 59
Increased T-cell receptor vbeta2 chain expression in skin homing lymphocytes in psoriasis.
###end article-title 59
###begin article-title 60
###xml 42 47 <span type="species:ncbi:9606">human</span>
Superantigens and their potential role in human disease.
###end article-title 60
###begin article-title 61
Superantigen mediated shock: a cytokine release syndrome.
###end article-title 61
###begin article-title 62
Induction of acute inflammatory lung injury by staphylococcal enterotoxin B. J Immunol
###end article-title 62
###begin article-title 63
###xml 42 46 <span type="species:ncbi:10090">mice</span>
T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.
###end article-title 63
###begin article-title 64
Interleukin-2: inception, impact, and implications.
###end article-title 64
###begin article-title 65
Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.
###end article-title 65
###begin article-title 66
###xml 36 41 <span type="species:ncbi:9606">human</span>
MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).
###end article-title 66
###begin article-title 67
SEB-induced signaling in macrophages leads to biphasic TNF-alpha.
###end article-title 67
###begin article-title 68
Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.
###end article-title 68
###begin article-title 69
Activation rules: the two-signal theories of immune activation.
###end article-title 69
###begin article-title 70
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Interferon gamma receptor deficient mice are resistant to endotoxic shock.
###end article-title 70
###begin article-title 71
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4.
###end article-title 71
###begin article-title 72
Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell-receptor VBeta2-positive T cells.
###end article-title 72
###begin article-title 73
IL-2, IL-4, and IFN-gamma gene expression versus secretion in superantigen-activated T cells. Distinct requirement for costimulatory signals through adhesion molecules.
###end article-title 73
###begin article-title 74
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.
###end article-title 74
###begin article-title 75
###xml 37 52 <span type="species:ncbi:10090">transgenic mice</span>
TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma.
###end article-title 75
###begin article-title 76
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Lethally irradiated normal strains of mice radioprotected with SCID bone marrow develop sensitivity to low doses of staphylococcal enterotoxin B. Immunol Lett
###end article-title 76
###begin article-title 77
Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo.
###end article-title 77
###begin p 78
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 78
###begin p 79
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Council of Scientific and Industrial Research (CSIR), Defence Research and Development Organization (DRDO), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 79

